Status
Conditions
About
This study will look for evidence that a virus called HHV-6B may be related to seizures and to a form of brain injury called mesial temporal sclerosis that is associated with seizures. The study will use new, more sensitive brain scans to try to detect brain regions that might be affected by the virus and will examine cerebrospinal fluid (CSF, the fluid that bathes the brain and spinal cord) for evidence of the virus as well.
Healthy volunteers and people with seizures uncontrolled by anti-epileptic drugs who are between 18 and 45 years of age may be eligible for this study. Candidates are screened with a physical examination and laboratory tests.
Participants undergo the following procedures:
Full description
Objectives: 1) to attempt to detect specific patterns of hippocampal injury in patients with temporal lobe epilepsy that may be associated with HHV-6B infection; 2) To attempt to detect evidence for persistent HHV6 infection in CSF in patients with refractory temporal lobe epilepsy. 3) to obtain preliminary pilot data on the ability of high resolution structural to detect abnormalities in epilepsy patients not seen with standard scanners.
Study Population: 45 patients with localization-related epilepsy; 45 healthy volunteers
Design: 1) imaging with a 7T MRI magnetic resonance scanner; 2) Lumbar puncture. 3) blood sampling
Main outcome measure: 1) Detection of evidence for HHV6 infection in CSF
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patients will be avaluated for participation under screening protocol 01-N-0139.
Patients
Male and female subjects age 18 to 55
Subjects with seizures uncontrolled by antiepileptic drugs
Subjects with no other illnesses, or taking other substances or medicines that could interfere with the study
Healthy Controls
Male and female subjects age 18 to 55.
EXCLUSION CRITERIA:
Patient
Subjects who are pregnant or breast feeding.
Subjects with any medical condition that could interfere with the study.
Subjects who are taking drugs that significantly reduce blood clotting such as Coumadin or Warfarin.
Healthy Volunteers
Subjects who are pregnant or breast feeding
Subjects who have any medical condition or be taking any substance or medication that could interfere with the study
Subjects who are taking drugs that significantly reduce blood cloting such as Coumadin or Warfarin
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal